Whole Network Gene Therapy Microbiology Nanomedicine Stem Cells

 

Nanogen, Inc Offers 6.8M Shares of Common Stock

Filed in archive Corporate and Industrial News by ruth on September 28, 2005

BlogPicture

Nanogen, Inc. announced today that it will sell 6.8 million shares of its common stock to institutional investors at a price of $2.94 per share, plus 1.0 million warrants exercisable at $4.00 per share for five years.

Nanogen develops diagnostic tools and reagents for researchers, clinicians and physicians, such as real-time PCR reagents, the NanoChip(R) Molecular biologylinks Workstation platform for molecular diagnostic applications and a line of rapid point-of-care diagnostic tests. Nanogen hopes to develop miniaturized diagnostic kits using nanotechnology.

Read nanogen's press release here. More on Nanogen stocks here.






Permalink: Nanogen, Inc Offers 6.8M Shares of Common Stock
Tags: diagnostics  stocks  biotech  nanogen  common  common+stock  shares+common  nanogen+offers 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/9812





RSSrss   | See all blog subscribe options
Google google   |   What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts



 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'


  • Other blogs in the same channel in the Creative Weblogging Network







 

Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells